Browsing Tag

Benitec Biopharma Inc.

Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering

Eli Pacheco Aug 12, 2023 0

HAYWARD, Calif., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company…

Health

Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program

Eli Pacheco Jan 23, 2023 0

HAYWARD, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company…